Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

106 Results

Guidelines and Advice

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma

Status: Archived
ID: 8-3

Sep 2011

Guidelines and Advice

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Status: Archived
ID: 12-6

May 2012

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Status: Current

Apr 2020

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

Status: Current
ID: GL-C50-29

Mar 2012

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Biosimilars

Symptom Management

Urinary Incontinence - Prostate Cancer

Symptom Management

Bowel Function - Prostate Cancer

Symptom Management

Urinary Problems - Prostate Cancer

Guidelines and Advice

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Status: Education and Information
ID: 1-2
Version: 2

Sep 2011

Pages